 | • レポートコード：GIR-2104Z13582 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、全身性自己免疫疾患診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。全身性自己免疫疾患診断の種類別市場規模（関節リウマチ、強直性脊椎炎、全身性エリテマトーデス（SLE）、その他）、用途別市場規模（病院、診療所、研究所、実験室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・全身性自己免疫疾患診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Hoffmann-La Roche Ltd、Siemens Healthineers、Abbott Laboratories、Beckman Coulter, Inc.、SQI Diagnostics、Quest Diagnostics、EUROIMMUN AG、AESKU.Diagnostics GmbH & Co. KG、INOVA Diagnostics, Inc.、Crescendo Bioscience, Inc.、bioMerieux SA、Bio-Rad Laboratories, Inc.、Hemagen Diagnostics, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：関節リウマチ、強直性脊椎炎、全身性エリテマトーデス（SLE）、その他 ・用途別分析2016年-2026年：病院、診療所、研究所、実験室 ・全身性自己免疫疾患診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・全身性自己免疫疾患診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・全身性自己免疫疾患診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・全身性自己免疫疾患診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・全身性自己免疫疾患診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Systemic Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Systemic Autoimmune Disease Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Systemic Autoimmune Disease Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Systemic Autoimmune Disease Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus (SLE)
Others
Market segment by Application, can be divided into
Hospital
Clinic
Research Institute
Laboratories
Market segment by players, this report covers
Hoffmann-La Roche Ltd
Siemens Healthineers
Abbott Laboratories
Beckman Coulter, Inc.
SQI Diagnostics
Quest Diagnostics
EUROIMMUN AG
AESKU.Diagnostics GmbH & Co. KG
INOVA Diagnostics, Inc.
Crescendo Bioscience, Inc.
bioMerieux SA
Bio-Rad Laboratories, Inc.
Hemagen Diagnostics, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Systemic Autoimmune Disease Diagnostics
1.2 Classification of Systemic Autoimmune Disease Diagnostics by Type
1.2.1 Overview: Global Systemic Autoimmune Disease Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Systemic Autoimmune Disease Diagnostics Revenue Market Share by Type in 2020
1.2.3 Rheumatoid Arthritis
1.2.4 Ankylosing Spondylitis
1.2.5 Systemic Lupus Erythematosus (SLE)
1.2.6 Others
1.3 Global Systemic Autoimmune Disease Diagnostics Market by Application
1.3.1 Overview: Global Systemic Autoimmune Disease Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.4 Global Systemic Autoimmune Disease Diagnostics Market Size & Forecast
1.5 Global Systemic Autoimmune Disease Diagnostics Market Size and Forecast by Region
1.5.1 Global Systemic Autoimmune Disease Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Systemic Autoimmune Disease Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Systemic Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Systemic Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Systemic Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Systemic Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Systemic Autoimmune Disease Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Systemic Autoimmune Disease Diagnostics Market Drivers
1.6.2 Systemic Autoimmune Disease Diagnostics Market Restraints
1.6.3 Systemic Autoimmune Disease Diagnostics Trends Analysis
2 Company Profiles
2.1 Hoffmann-La Roche Ltd
2.1.1 Hoffmann-La Roche Ltd Details
2.1.2 Hoffmann-La Roche Ltd Major Business
2.1.3 Hoffmann-La Roche Ltd Systemic Autoimmune Disease Diagnostics Product and Solutions
2.1.4 Hoffmann-La Roche Ltd Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.2 Siemens Healthineers
2.2.1 Siemens Healthineers Details
2.2.2 Siemens Healthineers Major Business
2.2.3 Siemens Healthineers Systemic Autoimmune Disease Diagnostics Product and Solutions
2.2.4 Siemens Healthineers Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Siemens Healthineers Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Systemic Autoimmune Disease Diagnostics Product and Solutions
2.3.4 Abbott Laboratories Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Beckman Coulter, Inc.
2.4.1 Beckman Coulter, Inc. Details
2.4.2 Beckman Coulter, Inc. Major Business
2.4.3 Beckman Coulter, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
2.4.4 Beckman Coulter, Inc. Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beckman Coulter, Inc. Recent Developments and Future Plans
2.5 SQI Diagnostics
2.5.1 SQI Diagnostics Details
2.5.2 SQI Diagnostics Major Business
2.5.3 SQI Diagnostics Systemic Autoimmune Disease Diagnostics Product and Solutions
2.5.4 SQI Diagnostics Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 SQI Diagnostics Recent Developments and Future Plans
2.6 Quest Diagnostics
2.6.1 Quest Diagnostics Details
2.6.2 Quest Diagnostics Major Business
2.6.3 Quest Diagnostics Systemic Autoimmune Disease Diagnostics Product and Solutions
2.6.4 Quest Diagnostics Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Quest Diagnostics Recent Developments and Future Plans
2.7 EUROIMMUN AG
2.7.1 EUROIMMUN AG Details
2.7.2 EUROIMMUN AG Major Business
2.7.3 EUROIMMUN AG Systemic Autoimmune Disease Diagnostics Product and Solutions
2.7.4 EUROIMMUN AG Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 EUROIMMUN AG Recent Developments and Future Plans
2.8 AESKU.Diagnostics GmbH & Co. KG
2.8.1 AESKU.Diagnostics GmbH & Co. KG Details
2.8.2 AESKU.Diagnostics GmbH & Co. KG Major Business
2.8.3 AESKU.Diagnostics GmbH & Co. KG Systemic Autoimmune Disease Diagnostics Product and Solutions
2.8.4 AESKU.Diagnostics GmbH & Co. KG Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AESKU.Diagnostics GmbH & Co. KG Recent Developments and Future Plans
2.9 INOVA Diagnostics, Inc.
2.9.1 INOVA Diagnostics, Inc. Details
2.9.2 INOVA Diagnostics, Inc. Major Business
2.9.3 INOVA Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
2.9.4 INOVA Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 INOVA Diagnostics, Inc. Recent Developments and Future Plans
2.10 Crescendo Bioscience, Inc.
2.10.1 Crescendo Bioscience, Inc. Details
2.10.2 Crescendo Bioscience, Inc. Major Business
2.10.3 Crescendo Bioscience, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
2.10.4 Crescendo Bioscience, Inc. Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Crescendo Bioscience, Inc. Recent Developments and Future Plans
2.11 bioMerieux SA
2.11.1 bioMerieux SA Details
2.11.2 bioMerieux SA Major Business
2.11.3 bioMerieux SA Systemic Autoimmune Disease Diagnostics Product and Solutions
2.11.4 bioMerieux SA Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 bioMerieux SA Recent Developments and Future Plans
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Bio-Rad Laboratories, Inc. Details
2.12.2 Bio-Rad Laboratories, Inc. Major Business
2.12.3 Bio-Rad Laboratories, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
2.12.4 Bio-Rad Laboratories, Inc. Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.13 Hemagen Diagnostics, Inc.
2.13.1 Hemagen Diagnostics, Inc. Details
2.13.2 Hemagen Diagnostics, Inc. Major Business
2.13.3 Hemagen Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
2.13.4 Hemagen Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Hemagen Diagnostics, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Systemic Autoimmune Disease Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Systemic Autoimmune Disease Diagnostics Players Market Share
3.2.2 Top 10 Systemic Autoimmune Disease Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Systemic Autoimmune Disease Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Systemic Autoimmune Disease Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Systemic Autoimmune Disease Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Systemic Autoimmune Disease Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Systemic Autoimmune Disease Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
6.2 North America Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
6.3 North America Systemic Autoimmune Disease Diagnostics Market Size by Country
6.3.1 North America Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
7.2 Europe Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
7.3 Europe Systemic Autoimmune Disease Diagnostics Market Size by Country
7.3.1 Europe Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Systemic Autoimmune Disease Diagnostics Market Size by Region
8.3.1 Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Region (2016-2026)
8.3.2 China Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
9.2 South America Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
9.3 South America Systemic Autoimmune Disease Diagnostics Market Size by Country
9.3.1 South America Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Systemic Autoimmune Disease Diagnostics Market Size by Country
10.3.1 Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Systemic Autoimmune Disease Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Systemic Autoimmune Disease Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Systemic Autoimmune Disease Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Systemic Autoimmune Disease Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Systemic Autoimmune Disease Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Systemic Autoimmune Disease Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 7. Hoffmann-La Roche Ltd Major Business
Table 8. Hoffmann-La Roche Ltd Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 9. Hoffmann-La Roche Ltd Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 11. Siemens Healthineers Major Business
Table 12. Siemens Healthineers Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 13. Siemens Healthineers Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 17. Abbott Laboratories Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beckman Coulter, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter, Inc. Major Business
Table 20. Beckman Coulter, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 21. Beckman Coulter, Inc. Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. SQI Diagnostics Corporate Information, Head Office, and Major Competitors
Table 23. SQI Diagnostics Major Business
Table 24. SQI Diagnostics Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 25. SQI Diagnostics Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 27. Quest Diagnostics Major Business
Table 28. Quest Diagnostics Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 29. Quest Diagnostics Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. EUROIMMUN AG Corporate Information, Head Office, and Major Competitors
Table 31. EUROIMMUN AG Major Business
Table 32. EUROIMMUN AG Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 33. EUROIMMUN AG Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AESKU.Diagnostics GmbH & Co. KG Corporate Information, Head Office, and Major Competitors
Table 35. AESKU.Diagnostics GmbH & Co. KG Major Business
Table 36. AESKU.Diagnostics GmbH & Co. KG Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 37. AESKU.Diagnostics GmbH & Co. KG Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. INOVA Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. INOVA Diagnostics, Inc. Major Business
Table 40. INOVA Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 41. INOVA Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Crescendo Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Crescendo Bioscience, Inc. Major Business
Table 44. Crescendo Bioscience, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 45. Crescendo Bioscience, Inc. Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. bioMerieux SA Corporate Information, Head Office, and Major Competitors
Table 47. bioMerieux SA Major Business
Table 48. bioMerieux SA Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 49. bioMerieux SA Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Bio-Rad Laboratories, Inc. Major Business
Table 52. Bio-Rad Laboratories, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 53. Bio-Rad Laboratories, Inc. Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Hemagen Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Hemagen Diagnostics, Inc. Major Business
Table 56. Hemagen Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Product and Solutions
Table 57. Hemagen Diagnostics, Inc. Systemic Autoimmune Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Systemic Autoimmune Disease Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 59. Global Systemic Autoimmune Disease Diagnostics Revenue Share by Players (2019-2021)
Table 60. Breakdown of Systemic Autoimmune Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Systemic Autoimmune Disease Diagnostics Players Head Office, Products and Services Provided
Table 62. Systemic Autoimmune Disease Diagnostics Mergers & Acquisitions in the Past Five Years
Table 63. Systemic Autoimmune Disease Diagnostics New Entrants and Expansion Plans
Table 64. Global Systemic Autoimmune Disease Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 65. Global Systemic Autoimmune Disease Diagnostics Revenue Share by Type (2016-2021)
Table 66. Global Systemic Autoimmune Disease Diagnostics Revenue Forecast by Type (2021-2026)
Table 67. Global Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2021)
Table 68. Global Systemic Autoimmune Disease Diagnostics Revenue Forecast by Application (2021-2026)
Table 69. North America Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Systemic Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Systemic Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Systemic Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Systemic Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Systemic Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Systemic Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Systemic Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Systemic Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Systemic Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Systemic Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Systemic Autoimmune Disease Diagnostics Picture
Figure 2. Global Systemic Autoimmune Disease Diagnostics Revenue Market Share by Type in 2020
Figure 3. Rheumatoid Arthritis
Figure 4. Ankylosing Spondylitis
Figure 5. Systemic Lupus Erythematosus (SLE)
Figure 6. Others
Figure 7. Systemic Autoimmune Disease Diagnostics Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Research Institute Picture
Figure 11. Laboratories Picture
Figure 12. Global Systemic Autoimmune Disease Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Systemic Autoimmune Disease Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Systemic Autoimmune Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 15. Global Systemic Autoimmune Disease Diagnostics Revenue Market Share by Region in 2020
Figure 16. North America Systemic Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Systemic Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Systemic Autoimmune Disease Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Systemic Autoimmune Disease Diagnostics Market Drivers
Figure 21. Systemic Autoimmune Disease Diagnostics Market Restraints
Figure 22. Systemic Autoimmune Disease Diagnostics Market Trends
Figure 23. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 24. Siemens Healthineers Recent Developments and Future Plans
Figure 25. Abbott Laboratories Recent Developments and Future Plans
Figure 26. Beckman Coulter, Inc. Recent Developments and Future Plans
Figure 27. SQI Diagnostics Recent Developments and Future Plans
Figure 28. Quest Diagnostics Recent Developments and Future Plans
Figure 29. EUROIMMUN AG Recent Developments and Future Plans
Figure 30. AESKU.Diagnostics GmbH & Co. KG Recent Developments and Future Plans
Figure 31. INOVA Diagnostics, Inc. Recent Developments and Future Plans
Figure 32. Crescendo Bioscience, Inc. Recent Developments and Future Plans
Figure 33. bioMerieux SA Recent Developments and Future Plans
Figure 34. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 35. Hemagen Diagnostics, Inc. Recent Developments and Future Plans
Figure 37. Global Systemic Autoimmune Disease Diagnostics Revenue Share by Players in 2020
Figure 38. Systemic Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Systemic Autoimmune Disease Diagnostics Revenue Market Share in 2020
Figure 40. Global Top 10 Players Systemic Autoimmune Disease Diagnostics Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Systemic Autoimmune Disease Diagnostics Revenue Share by Type in 2020
Figure 43. Global Systemic Autoimmune Disease Diagnostics Market Share Forecast by Type (2021-2026)
Figure 44. Global Systemic Autoimmune Disease Diagnostics Revenue Share by Application in 2020
Figure 45. Global Systemic Autoimmune Disease Diagnostics Market Share Forecast by Application (2021-2026)
Figure 46. North America Systemic Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 47. North America Systemic Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 48. North America Systemic Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 49. United States Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Systemic Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 53. Europe Systemic Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 54. Europe Systemic Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 55. Germany Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Systemic Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Systemic Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Systemic Autoimmune Disease Diagnostics Revenue Market Share by Region (2016-2026)
Figure 63. China Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Systemic Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 70. South America Systemic Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 71. South America Systemic Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Systemic Autoimmune Disease Diagnostics Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Systemic Autoimmune Disease Diagnostics Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Systemic Autoimmune Disease Diagnostics Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Systemic Autoimmune Disease Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の限局性自己免疫疾患診断市場 2021：企業別、地域別、種類・用途別 The Localized Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- 世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年） The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific. In terms of geography, the Americas led the …
- 世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Disease Diagnosis Market The global Autoimmune Disease Diagnosis market size is projected to reach US$ 4227.9 million by 2026, from US$ 2983.8 million in 2019, at a CAGR of 5.0% during 2021-2026. With industry-standard accuracy in analysis and high dat…
- 世界の全身性特発性若年性関節炎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
- 世界の自己免疫治療薬市場規模・現状・予測（2021年-2027年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…